Market Overview:
The global fenofibrate market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of obesity and metabolic syndrome, rising awareness about the benefits of fenofibrate therapy, and growing demand for generic drugs. Fenofibrate is available in tablet and capsule form, which are used for treating hyperlipidemia (high levels of fats or lipids in the blood) and other conditions such as diabetes mellitus, coronary heart disease (CHD), stroke, chronic kidney disease (CKD), nonalcoholic fatty liver disease (NAFLD), and polycystic ovary syndrome (PCOS). North America dominates the global fenofibrate market due to high prevalence of obesity and metabolic syndrome in this region.
Product Definition:
fenofibrate (FEN oh FYE brayt) is a drug used to lower cholesterol and triglycerides in the blood. It is used to treat high cholesterol and high triglycerides. Fenofibrate may also be used for other purposes not listed in this medication guide.
Tablet:
Tablet is a thin piece of plastic or other material, which is used as an input device to display information. It has a size of less than 9 inches and can be held in the hand. The first tablet was launched by IBM in April 2000. Since then, it has become one of the most popular input devices for computers all over the world due to its portability and versatility.
Capsule:
A capsule is a small container made up of glass or plastic and is used to hold the medication. It is usually oval in shape and size ranging from 2-3 mm thick. The types of capsules include gelatin, soft gel, film-based, and liquid filled capsules among others. Capsules are widely used for packaging drugs as they provide physical protection from sunlight, moisture & temperature among other things.
Application Insights:
The global fenofibrate market is segmented by application into hospital, drug store and others. The hospital segment dominated the overall industry in terms of revenue in 2017. This high share is attributable to a large number of patients suffering from cardiovascular diseases and other heart-related disorders requiring medication. Moreover, increasing awareness about the availability of various healthcare facilities along with rising prevalence rates are further driving demand for fenofibrate tablets in hospitals across the globe.
The drug store or retail pharmacy was the second largest application segment accounting for over 25% share of total revenue in 2017 due to growing penetration levels coupled with rising preference towards online medical shopping among consumers globally.
Regional Analysis:
Europe dominated the global market in 2017. The region is expected to witness a CAGR of XX% over the forecast period, owing to rising product demand from countries such as Germany and U.K.
Asia Pacific is anticipated to be one of the fastest-growing regional markets due to increasing awareness about products and growing population suffering from obesity disease across countries such as China, India.
Growth Factors:
- Increasing prevalence of obesity and metabolic syndrome
- Rising geriatric population
- Growing demand for combination therapies
- Technological advancements in fenofibrate drug delivery systems
- increasing awareness about the benefits of fenofibrate therapy
Scope Of The Report
Report Attributes
Report Details
Report Title
Fenofibrate Market Research Report
By Type
Tablet, Capsule
By Application
Hospital, Drug Store
By Companies
AbbVie, Lupin, Salix Pharmaceuticals, Vectura, Cipher Pharmaceuticals, Rhodes Pharmaceuticals, Impax Laboratories, Mylan, Teva, Sun Pharmaceutical, AbbVie, HETERO, Aurobindo Pharma, Cipla, Amneal Pharmaceuticals, Prinston Pharmaceutical, Dr. Reddys Laboratories, APOTEX, Glenmark
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Fenofibrate Market Report Segments:
The global Fenofibrate market is segmented on the basis of:
Types
Tablet, Capsule
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AbbVie
- Lupin
- Salix Pharmaceuticals
- Vectura
- Cipher Pharmaceuticals
- Rhodes Pharmaceuticals
- Impax Laboratories
- Mylan
- Teva
- Sun Pharmaceutical
- AbbVie
- HETERO
- Aurobindo Pharma
- Cipla
- Amneal Pharmaceuticals
- Prinston Pharmaceutical
- Dr. Reddys Laboratories
- APOTEX
- Glenmark
Highlights of The Fenofibrate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablet
- Capsule
- By Application:
- Hospital
- Drug Store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Fenofibrate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Fenofibrate is a medication used to lower blood triglycerides. It is also used to treat heart disease and other conditions. Fenofibrate works by increasing the amount of HDL (good) cholesterol in the blood.
Some of the major companies in the fenofibrate market are AbbVie, Lupin, Salix Pharmaceuticals, Vectura, Cipher Pharmaceuticals, Rhodes Pharmaceuticals, Impax Laboratories, Mylan, Teva, Sun Pharmaceutical, AbbVie, HETERO, Aurobindo Pharma, Cipla, Amneal Pharmaceuticals, Prinston Pharmaceutical, Dr. Reddys Laboratories, APOTEX, Glenmark.
The fenofibrate market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Fenofibrate Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Fenofibrate Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Fenofibrate Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Fenofibrate Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Fenofibrate Market Size & Forecast, 2020-2028
4.5.1 Fenofibrate Market Size and Y-o-Y Growth
4.5.2 Fenofibrate Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Tablet
5.2.2 Capsule
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Fenofibrate Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Fenofibrate Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Tablet
9.6.2 Capsule
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Tablet
10.6.2 Capsule
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Tablet
11.6.2 Capsule
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Tablet
12.6.2 Capsule
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Tablet
13.6.2 Capsule
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Fenofibrate Market: Competitive Dashboard
14.2 Global Fenofibrate Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AbbVie
14.3.2 Lupin
14.3.3 Salix Pharmaceuticals
14.3.4 Vectura
14.3.5 Cipher Pharmaceuticals
14.3.6 Rhodes Pharmaceuticals
14.3.7 Impax Laboratories
14.3.8 Mylan
14.3.9 Teva
14.3.10 Sun Pharmaceutical
14.3.11 AbbVie
14.3.12 HETERO
14.3.13 Aurobindo Pharma
14.3.14 Cipla
14.3.15 Amneal Pharmaceuticals
14.3.16 Prinston Pharmaceutical
14.3.17 Dr. Reddys Laboratories
14.3.18 APOTEX
14.3.19 Glenmark
